Endometriosis Terminated Phase 2 Trials for Elagolix (DB11979)

Also known as: Sigmoid endometriosis / Endometriosis, unspecified / Endometriosis (morphologic abnormality) / Endometriosis (disorder) / Endometriosis, site unspecified

IndicationStatusPhase
DBCOND0001340 (Endometriosis)Terminated2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT04614246Study to Gather Information How Well Three Different Doses of BAY1817080 Given Twice Daily Over 12 Weeks Work in Comparison to an Inactive Pill (Placebo) and Elagolix in Women Suffering From Pain Related to a Condition Where the Tissue That Usually Grows Inside the Womb Grows Outside of the WombTreatment